C2 Dihydro Ceramide (d18:0/2:0)

CAS No. 13031-64-6

C2 Dihydro Ceramide (d18:0/2:0)( —— )

Catalog No. M37538 CAS No. 13031-64-6

C2 Dihydro Ceramide (d18:0/2:0) (C2 Dihydroceramide) is a short-chain ceramide that is a precursor of ceramide synthesis and stimulates ABCA1-mediated cholesterol efflux.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 555 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    C2 Dihydro Ceramide (d18:0/2:0)
  • Note
    Research use only, not for human use.
  • Brief Description
    C2 Dihydro Ceramide (d18:0/2:0) (C2 Dihydroceramide) is a short-chain ceramide that is a precursor of ceramide synthesis and stimulates ABCA1-mediated cholesterol efflux.
  • Description
    C2 Dihydro Ceramide (d18:0/2:0) (C2 Dihydroceramide) is a short-chain ceramide that is a precursor of ceramide synthesis and stimulates ABCA1-mediated cholesterol efflux.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Endogenous Metabolite
  • Recptor
    Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13031-64-6
  • Formula Weight
    343.54
  • Molecular Formula
    C20H41NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H]([C@@H](CCCCCCCCCCCCCCC)O)(NC(C)=O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tiglyl carnitine

    Tiglyl carnitine is associated with lung cancer and carnitine and glycine to 3-ketothiolase deficiency .

  • 2-hydroxymethyl benz...

    2-hydroxymethyl benzoic acid is a principal metabolite of the phthalidyl moiety in man.

  • PAPA NONOate

    PAPA NONOate is a pH-regulated NO donor.PAPA NONOate has potential antitumor activity and can be used to study diabetic wound healing disorders.